Yunnan draws a 5-year development blueprint to build China's "medicine creation" highland

The pharmaceutical industry is an important industry closely related to people's life and health, and it is also a national strategic emerging industry.
With the successive promulgation and implementation of a series of documents and regulations such as "Made in China 2025" and "Healthy China 2030 Planning Outline", the development of the biopharmaceutical industry has enjoyed a strong momentum.
With strong policy and regulatory support, opportunities are further emerging, while challenges still coexist
.
In order to solve the existing problems such as weak product competitiveness and adaptability, unreasonable industrial structure, and difficulty in talent introduction, the Yunnan Provincial Department of Industry and Information Technology recently issued the "14th Five-Year Plan for the Development of Pharmaceutical Industry in Yunnan Province".
Focus on advantageous and characteristic fields such as biotechnology medicine, characteristic traditional Chinese medicine, chemical medicine, and general health, draw a five-year development blueprint, and create a highland of "medicine creation" in China
.
According to the development goals of Yunnan Province, by 2025, the output value of the province's pharmaceutical industry will exceed 120 billion yuan, and the average annual growth rate will remain above 25%
.
The status of the pharmaceutical industry in the entire industry has been further strengthened; there are more than 300 enterprises above the scale, 2-3 industrial enterprises with an annual output value of more than 10 billion yuan, and 5-10 industrial enterprises with an output value of more than 1 billion yuan
.
According to the key development direction and industrial layout of the province, we will innovate and develop the biopharmaceutical industry with vaccines as the core, optimize and refine the traditional Chinese medicine industry, enhance the development of the chemical drug industry, give priority to the development of the medical beauty and health care industry, and actively deploy the medical device industry.
and so on
.
Among them, in the field of proprietary Chinese medicines, it is clear to accelerate the development of traditional Chinese medicines and ethnic medicine products, explore and develop the formulations and prescriptions of ethnic medicines with folk characteristics, and develop new in-hospital preparations of ethnic medicines
.
Increase the in-depth development of in-hospital preparations for ethnic medicines with definite curative effect, clear mechanism of action, mature and reliable, apply for the approval number of ethnic medicines, cultivate clusters of ethnic medicines, and provide variety support for the development of ethnic medicines
.
Increase the technical upgrade and quality improvement of ethnic medicines with clear mechanism of action, high technical content and reliable efficacy, and increase the secondary development of new indications, new dosage forms, and new routes of administration
.
For the dominant varieties already on the market, re-evaluation of the efficacy, safety, preparation process and quality control of the drugs after the market is carried out
.
For the traditional Chinese medicine formula granule industry, support and encourage key enterprises of traditional Chinese medicine formula granules in the province to actively participate in the drafting and formulation of national standards, so as to enhance the voice and competitiveness of the enterprise industry
.
According to the characteristics of traditional Chinese medicine formula granules, enterprises are encouraged to establish an online medical treatment platform to provide traditional Chinese medicine formula granules online for returning patients, and promote the sales model of "smart pharmacy" and "smart medical treatment"
.
The concept of using traditional Chinese medicine to treat diseases is deeply rooted in the hearts of the people, and vigorously develops health-care traditional Chinese medicine formula granules
.
Actively promote the standardization of traditional Chinese medicine, focusing on the whole production process of Chinese herbal medicine planting, processing and preparation, and production of Chinese herbal decoction pieces, and improve and revise a batch of standards for the whole process of traditional Chinese medicine production
.
Encourage the development of refined decoction pieces, decoction-free decoction pieces, small packaged decoction pieces and other new-type decoction pieces
.
Focus on promoting the standardized planting of authentic varieties such as Panax notoginseng, Tianma, Chonglou, Yunmuxiang, Amomum, Dengzhanhua, Dendrobium candidum, Yundanggui, and Yunnan gentian, and strengthen scientific guidance on the cultivation and breeding of Chinese medicinal materials
.
Yunnan Province has obvious advantages in the sub-industry of traditional Chinese medicine, and the planting area of ​​traditional Chinese medicine ranks first in the country
.
At present, large-scale domestic Chinese medicine enterprises such as Yunnan Baiyao, Kunyao Group, Bio Valley and Longjin Pharmaceutical have gathered together, and the benefits of giants have continued to emerge, creating “Top Ten Cloud Medicine” brands such as Panax notoginseng and Yunfuling
.
With the release of Yunnan Province's "14th Five-Year" pharmaceutical industry development plan, it will further help the high-quality development of the pharmaceutical industry including the traditional Chinese medicine industry
.